Please wait while we load the requested 10-K report or click the link below:
Walgreens Boots Alliance Reports Fourth Quarter and Fiscal 2016 Results
Fourth quarter highlights
|||GAAP diluted net earnings per share increase to $0.95 from $0.02 in the year-ago quarter; Adjusted diluted net earnings per share increase 21.6 percent to $1.07|
|||GAAP net earnings attributable to Walgreens Boots Alliance increase to $1.0 billion compared with $26 million in the year-ago quarter; Adjusted net earnings attributable to Walgreens Boots Alliance increase 20.3 percent to $1.2 billion|
|||Sales increase 0.4 percent to $28.6 billion, up 2.5 percent on a constant currency basis|
|||GAAP operating income increases 36.4 percent to $1.1 billion; Adjusted operating income increases 7.2 percent to $1.6 billion, up 10.3 percent on a constant currency basis|
Fiscal 2016 highlights
|||GAAP diluted net earnings per share decrease 4.5 percent from the prior year, to $3.82; Adjusted diluted net earnings per share increase 18.3 percent to $4.59|
|||GAAP net earnings attributable to Walgreens Boots Alliance decrease 1.1 percent to $4.2 billion; Adjusted net earnings attributable to Walgreens Boots Alliance increase 22.6 percent to $5.0 billion|
|||Sales increase 13.4 percent to $117.4 billion, largely due to inclusion of Alliance Boots consolidated results for the entire year|
|||GAAP operating income increases 28.6 percent to $6.0 billion; Adjusted operating income increases 17.1 percent to $7.2 billion, up 18.9 percent on a constant currency basis|
|||GAAP net cash provided by operating activities increases $2.2 billion to $7.8 billion and free cash flow increases $2.1 billion to $6.5 billion, compared with the prior year|
Fiscal 2017 guidance
|||Company introduces guidance of $4.85 to $5.20 for fiscal year 2017 adjusted diluted net earnings per share|
DEERFIELD, Ill., 20 October 2016 Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the fourth quarter and fiscal year 2016 that ended 31 August 2016.
Executive Vice Chairman and CEO Stefano Pessina said, We have continued to make good progress in putting in place the building blocks for the future growth of the business. The exercise of the AmerisourceBergen warrants in August provides an example of the opportunities open to us to deploy capital, and the agreements we reached with Prime Therapeutics and with Express Scripts during the quarter demonstrate our commitment to a more collaborative and partnership-oriented approach. We believe this can help provide growth for our own company and that of our strategic partners while delivering better, more efficient and more effective service to patients and payers alike.
Overview of Fourth Quarter Results
Fiscal 2016 fourth quarter net earnings attributable to Walgreens Boots Alliance determined in accordance with GAAP were $1.0 billion compared with $26 million in the same quarter a year ago,
The following information was filed by Walgreens Boots Alliance, Inc. (WBA) on Thursday, October 20, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Walgreens Boots Alliance, Inc.'s financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Walgreens Boots Alliance, Inc..